Ticker: NVO | Published: 2026-09-17
EU Drug Backing
Shares are rallying sharply after European regulators recommended approval for its hemophilia therapy Frehemgo alongside a new oral cardiometabolic drug collaboration with Orbis Medicines.
Sources: https://vertexaisearch.cloud.google.com/grounding-api-redirect/AUZIYQGR-PCGx4Q6YfxewGiCRKexUmMxs3A7quzWxJFzs0sEoRTkb1GfrzeLimgQsTItfz_4vB_kvR2ZMflpBJ23rHzAxYxSw8